Yixuan Liu

Yixuan Liu

Auto-generated profile, based on publicly available information

Yixuan Liu

Biochemical Engineering Group, Plant Biochemistry Section, Department of Plant and Environmental Sciences, University of Copenhagen, 1871 Frederiksberg C, Denmark

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SDSimon Dusséaux
Simon Dusséaux
WWWilliam Thomas Wajn
William Thomas Wajn
YLYixuan Liu
Yixuan Liu
CICodruta Ignea
Codruta Ignea
SKSotirios Kampranis
Sotirios Kampranis
Current approaches for the production of high-value compounds in microorganisms mostly use the cytosol as a general reaction vessel. However, competing pathways and metabolic cross-talk frequently prevent efficient synthesis of target compounds in the cytosol. Eukaryotic cells control the complexity of their metabolism by harnessing organelles to insulate biochemical pathways. Inspired by this concept, herein we transform yeast peroxisomes into microfactories for geranyl diphosphate-derived compounds, focusing on monoterpenoids, monoterpene indole alkaloids, and cannabinoids. We introduce a complete mevalonate pathway in the peroxisome to convert acetyl-CoA to several commercially important monoterpenes and achieve up to 125-fold increase over cytosolic production. Furthermore, peroxisomal production improves subsequent decoration by cytochrome P450s, supporting efficient conversion of (S)-(-)-limonene to the menthol precursor trans-isopiperitenol. We also establish synthesis of 8-hydroxygeraniol, the precursor of monoterpene indole alkaloids, and cannabigerolic acid, the cannabinoid precursor. Our findings establish peroxisomal engineering as an efficient strategy for the production of isoprenoids. Significance Monoterpenoids, monoterpene indole alkaloids, and cannabinoids are highly valued for their fragrant and therapeutic properties, but sourcing them from nature or deriving them from petrochemicals is no longer sustainable. However, sustainable production of these compounds in engineered microorganisms is mostly hampered by the limited availability of the main building block in their biosynthesis, geranyl diphosphate. Here, we overcome this challenge by engineering yeast peroxisomes as geranyl diphosphate-synthesizing microfactories and unlock the potential of yeast to produce a wide range of high-value isoprenoids. Conceptually, in this work we develop peroxisomes as synthetic biology devices that can be used for the modular assembly and optimization of complex pathways, adding an extra level of hierarchical abstraction in the systematic engineering of cell factories.